Plasma Citrulline Level in Relation to Absorptive Surface

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00286039
First received: February 1, 2006
Last updated: September 29, 2011
Last verified: September 2011

February 1, 2006
September 29, 2011
August 2005
September 2010   (final data collection date for primary outcome measure)
  • Correlation between determination of citrulline in plasma or dried blood [ Time Frame: Untill end of study ] [ Designated as safety issue: No ]
  • Reference ranges for healthy children and babies [ Time Frame: Until end of study ] [ Designated as safety issue: No ]
  • Longitudinal follow-up of citrulline in preterm babies [ Time Frame: Untill end of study ] [ Designated as safety issue: No ]
  • Correlation between determination of citrulin on plasma or dried blood
  • Develoment of reference ranges for healthy children and babies
  • Longitudinal follow-up of citrulin of preterm babies
  • Study to compare the biochrom amino acids analyser and the LC-MSMS regarding the reproducibility and costs
Complete list of historical versions of study NCT00286039 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Plasma Citrulline Level in Relation to Absorptive Surface
Plasma Citrulline Level in Relation to Absorptive Surface

Correlation between determination of citrulline in plasma or dried blood

Reference ranges for healthy children and babies

Longitudinal follow-up of citrulline in preterm babies

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Intestinal "Failure"
Procedure: Blood sampling
Blood sampling is used.
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
200
September 2010
September 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 0-18 years
  • preterm babies up to 1.500g
  • preterm babies over 1.500g

Exclusion Criteria:

  • gastro-intestinal problems (except for the preterm babies)
  • congenital metabolic disorders
  • dysfunction of the liver or kidneys
  • congenital defects
Both
up to 18 Years
No
Contact information is only displayed when the study is recruiting subjects
Belgium
 
NCT00286039
2005/163
No
University Hospital, Ghent
University Hospital, Ghent
Not Provided
Principal Investigator: Eddy Robberecht, MD, PhD University Hospital, Ghent
University Hospital, Ghent
September 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP